These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


458 related items for PubMed ID: 17331188

  • 21. Rat nicastrin gene: cDNA isolation, mRNA variants and expression pattern analysis.
    Confaloni A, Crestini A, Albani D, Piscopo P, Campeggi LM, Terreni L, Tartaglia M, Forloni G.
    Brain Res Mol Brain Res; 2005 May 20; 136(1-2):12-22. PubMed ID: 15893582
    [Abstract] [Full Text] [Related]

  • 22. Tau and saitohin gene expression pattern in progressive supranuclear palsy.
    Ezquerra M, Gaig C, Ascaso C, Muñoz E, Tolosa E.
    Brain Res; 2007 May 11; 1145():168-76. PubMed ID: 17320831
    [Abstract] [Full Text] [Related]

  • 23. CD36 overexpression in human brain correlates with beta-amyloid deposition but not with Alzheimer's disease.
    Ricciarelli R, D'Abramo C, Zingg JM, Giliberto L, Markesbery W, Azzi A, Marinari UM, Pronzato MA, Tabaton M.
    Free Radic Biol Med; 2004 Apr 15; 36(8):1018-24. PubMed ID: 15059642
    [Abstract] [Full Text] [Related]

  • 24. CREB activates proteasomal degradation of DSCR1/RCAN1.
    Seo SR, Chung KC.
    FEBS Lett; 2008 Jun 11; 582(13):1889-93. PubMed ID: 18485898
    [Abstract] [Full Text] [Related]

  • 25. Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer's disease.
    Lee HG, Ogawa O, Zhu X, O'Neill MJ, Petersen RB, Castellani RJ, Ghanbari H, Perry G, Smith MA.
    Acta Neuropathol; 2004 Apr 11; 107(4):365-71. PubMed ID: 14872255
    [Abstract] [Full Text] [Related]

  • 26. Hippocampal estrogen receptor-alpha splice variant TADDI in the human brain in aging and Alzheimer's disease.
    Ishunina TA, Swaab DF.
    Neuroendocrinology; 2009 Apr 11; 89(2):187-99. PubMed ID: 18815440
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Extracellular protein deposition correlates with glial activation and oxidative stress in Creutzfeldt-Jakob and Alzheimer's disease.
    Van Everbroeck B, Dobbeleir I, De Waele M, De Leenheir E, Lübke U, Martin JJ, Cras P.
    Acta Neuropathol; 2004 Sep 11; 108(3):194-200. PubMed ID: 15221335
    [Abstract] [Full Text] [Related]

  • 31. Expression of LIF and LIF receptor beta in Alzheimer's and Parkinson's diseases.
    Soilu-Hänninen M, Broberg E, Röyttä M, Mattila P, Rinne J, Hukkanen V.
    Acta Neurol Scand; 2010 Jan 11; 121(1):44-50. PubMed ID: 20074285
    [Abstract] [Full Text] [Related]

  • 32. Chronic high levels of the RCAN1-1 protein may promote neurodegeneration and Alzheimer disease.
    Ermak G, Davies KJA.
    Free Radic Biol Med; 2013 Sep 11; 62():47-51. PubMed ID: 23369757
    [Abstract] [Full Text] [Related]

  • 33. Evidence of a role for lactadherin in Alzheimer's disease.
    Boddaert J, Kinugawa K, Lambert JC, Boukhtouche F, Zoll J, Merval R, Blanc-Brude O, Mann D, Berr C, Vilar J, Garabedian B, Journiac N, Charue D, Silvestre JS, Duyckaerts C, Amouyel P, Mariani J, Tedgui A, Mallat Z.
    Am J Pathol; 2007 Mar 11; 170(3):921-9. PubMed ID: 17322377
    [Abstract] [Full Text] [Related]

  • 34. Sp3 and sp4 transcription factor levels are increased in brains of patients with Alzheimer's disease.
    Boutillier S, Lannes B, Buée L, Delacourte A, Rouaux C, Mohr M, Bellocq JP, Sellal F, Larmet Y, Boutillier AL, Loeffler JP.
    Neurodegener Dis; 2007 Mar 11; 4(6):413-23. PubMed ID: 17934324
    [Abstract] [Full Text] [Related]

  • 35. Presenilin-1 immunoreactivity is localized intracellularly in Alzheimer's disease brain, but not detected in amyloid plaques.
    Weber LL, Leissring MA, Yang AJ, Glabe CG, Cribbs DH, LaFerla FM.
    Exp Neurol; 1997 Jan 11; 143(1):37-44. PubMed ID: 9000444
    [Abstract] [Full Text] [Related]

  • 36. Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray.
    Hata R, Masumura M, Akatsu H, Li F, Fujita H, Nagai Y, Yamamoto T, Okada H, Kosaka K, Sakanaka M, Sawada T.
    Biochem Biophys Res Commun; 2001 Jun 08; 284(2):310-6. PubMed ID: 11394878
    [Abstract] [Full Text] [Related]

  • 37. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease.
    Dei R, Takeda A, Niwa H, Li M, Nakagomi Y, Watanabe M, Inagaki T, Washimi Y, Yasuda Y, Horie K, Miyata T, Sobue G.
    Acta Neuropathol; 2002 Aug 08; 104(2):113-22. PubMed ID: 12111353
    [Abstract] [Full Text] [Related]

  • 38. Aneuploidy in the normal, Alzheimer's disease and ataxia-telangiectasia brain: differential expression and pathological meaning.
    Iourov IY, Vorsanova SG, Liehr T, Yurov YB.
    Neurobiol Dis; 2009 May 08; 34(2):212-20. PubMed ID: 19344645
    [Abstract] [Full Text] [Related]

  • 39. Estrogen receptor alpha and its splice variants in the hippocampus in aging and Alzheimer's disease.
    Ishunina TA, Fischer DF, Swaab DF.
    Neurobiol Aging; 2007 Nov 08; 28(11):1670-81. PubMed ID: 17010478
    [Abstract] [Full Text] [Related]

  • 40. [Preliminary results of the study of neuronal death and the expression of bcl-2 protein in Alzheimer's disease].
    Erro E, Tuñón T.
    Rev Med Univ Navarra; 1997 Nov 08; 41(1):28-33. PubMed ID: 9580053
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 23.